Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-21-038823
Filing Date
2021-10-04
Accepted
2021-10-04 16:34:18
Documents
1
Period of Report
2021-10-01

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4063
  Complete submission text file 0000899243-21-038823.txt   5482
Mailing Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139
Business Address 100 TECHNOLOGY SQUARE 5TH FLOOR CAMBRIDGE MA 02139 857-201-2700
Magenta Therapeutics, Inc. (Issuer) CIK: 0001690585 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O CONSTELLATION PHARMACEUTICALS, INC. 215 FIRST STREET, SUITE 200 CAMBRIDGE MA 02142
Business Address
Humphrey Jeffrey (Reporting) CIK: 0001816944 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38541 | Film No.: 211303321